Cell Isolation
Dissected RA, MA, and CA were used for isolation of individual myocytes. Vessels were bathed for 10 minutes in a nominally Ca 2+ -free solution (in mmol/L: 6 KCl, 120 NaCl, 1.2 MgCl 2 , 12 D-glucose, and 10 HEPES, pH 7.4 with NaOH). Vessels were then incubated at 37°C for 17 (MA and CA) or 23 (RA) minutes in Ca 2+ -free solution containing in mg/mL: 1.5 collagenase, 0.75 thermolysin, 1 trypsin inhibitor, and 1 BSA. Vessels were then washed in Ca 2+ -free solution for 10 minutes and then triturated to liberate myocytes. The cell solution was plated on 13 mm coverslips in a 24-well plate and supplemented with an equivalent volume of 2.5 mmol/L Ca 2+ solution to allow the cells to adhere.
Gene Knockdown
To study the specific role of Kv7.4 in vascular relaxations, knockdown of Kv7.4 in MA, RA, and CA was performed by transfection with morpholino nucleotides as described in vessels previously. 13 Kv7.4 morpholino nucleotides 14 and mismatched control nucleotides (5 µmol/L, Genetools) were mixed with lipofectamine 2000 (Life Technologies) in Opti-MEM and left at room temperature for 2 hours. RA, MA, and CA were transfected with this mix in DMEM F-12 with 1% penicillin/streptomycin at 37°C for 48 hours.
Western Blot
Lysates were run on polyacrylamide gels (4%-12% Bis-Tris, Thermo-Fisher) and then transferred onto a polyvinylidene fluoride membrane (Millipore). The membrane was probed with primary antibodies diluted in blocking buffer (5% milk in PBS-Tween 20) overnight at 4°C. Primary antibodies used were (1) rabbit anti-Kv7. 4 (1:200; sc-50417; Santa Cruz) and (2) mouse anti-β-actin (1:5000; A1978; Sigma Aldrich). Anti-rabbit and anti-mouse secondary antibodies conjugated to IRDye 800RD and IRDye 680CW, respectively (dil.1:10,000; Li-Cor Biosciences), were used as appropriate. Protein bands were visualized using the Odyssey Infrared Imaging System (Li-Cor Biosciences, Cambridge, United Kingdom). Protein band intensities were measured using Image Studio software (Li-Cor Biosciences, Cambridge, United Kingdom) and normalized to β-actin. Data were analyzed by Mann-Whitney test, where n represents the number of animals used.
Immunofluorescence
Freshly isolated myocytes from CAs from vessels transfected with mismatched or Kv7.4 morpholino were prepared as above. Cells were fixed with 3% paraformaldehyde on ice for 20 minutes and stored in PBS at 4°C. For immunofluorescence, cells were treated with 0.1 mol/L glycine for 5 minutes and incubated in blocking solution (PBS containing 0.1% Triton X-100 and 1% BSA) for 1 hour at room temperature. Cells were then incubated overnight at 4°C with the following primary antibodies: (1) rabbit anti-Kv7.4 antibody (dilution 1:100, AbCam, Cambridge, United Kingdom); (2) mouse anti-α-smooth muscle actin (dilution 1:500, Sigma, Dorset, United Kingdom). Samples were then washed with PBS and incubated for 1 hour with donkey anti-rabbit and donkey anti-mouse secondary antibodies conjugated to Alexa Fluor 568 or Alexa Fluor 488, respectively (dilution 1:100, Thermo-Fisher, Paisley, United Kingdom). All antibodies were diluted in blocking solution. Subsequently, samples were washed with PBS and mounted using Vectashield Antifade Medium containing DAPI (4',6-diamidino-2-phenylindole) for nuclei counterstaining (Vector Laboratories, Peterborough, United Kingdom). Coverslips were analyzed using a Zeiss LSM 510 Meta argon/krypton laser scanning confocal microscope (Carl Zeiss, Jena, Germany). Corrected total cell fluorescence was calculated using ImageJ software as elsewhere described. 15 The number of cells analyzed is indicated by n, whereas N represents the number of animals used. Statistical analysis were performed by Student t test.
Myography
RA, MA, and CA were mounted in myographs (Danish Myograph Technologies) for isometric tension recording. Chambers were filled with physiological saline solution and aerated with 95% O 2 /5% CO 2 at 37°C. After normalization to 90% of vessel diameter at 100 mg Hg, vessels were constricted with 1 µmol/L methoxamine (RA) and 300 nmol/L U46619 (MA and CA). Relaxation dose responses to isoproterenol or CGRP were performed in the presence and absence of Gβγ inhibitors (M119K and gallein 16 ), Kv7.4 knockdown, or cell signaling inhibitors (see Reagents). Detailed information on level of vessel contraction in experiments, % maximal relaxation levels, and IC 50 s can be found in Tables I to VI in the online-only Data Supplement. Statistical analyses used a repeated measures 2-way ANOVA with Bonferroni post hoc analysis. For all myography experiments, vessels from 1 animal were used in a 4-chamber myograph allowing for different experiments to be conducted simultaneously but always including a same day control. The n number provided represents both the number of experiments performed and the number of animals used.
Proximity Ligation Assay
Freshly isolated cells wells were used as described above. A total of 1 mL of solution containing 2.5 mmol/L CaCl 2 was added to each well, and cells were placed in an incubator (37°C, 5% CO 2 9 Experiments were performed as per manufacturer's instructions; primary antibodies were incubated at 1:200 overnight at 4°C. Red fluorescent oligonucleotides produced as the end product of the procedure were visualized using a Zeiss Confocal LSM 510. Images were analyzed using Image J software using the particle detector tool. The number of puncta per cell was calculated as the average of 2 mid sections in each cell. The number of cells analyzed is indicated by n, whereas N represents the number of animals used. 
Results

Kv7.4 Morpholino-Directed Knockdown in the Rat Vasculature
To confirm a role for Kv7.4 in vasodilator responses, we used vessels where Kv7.4 was knocked down by morpholino transfection. Protein knockdown of Kv7.4 was confirmed by
Western blot in RA and MA ( Figure 1A and 1B). Kv7.4 knockdown produced a significant leftward shift in the dose response to methoxamine (RA) and U46619 (MA; Figure 1C and 1D). Functional impairment of channel activity was confirmed by attenuated responses to 2 Kv7 channel activators, ML213 and ICA-069673 ( Figure 1E and 1F). We next looked at the effect of Kv7.4 knockdown on isoproterenol-evoked relaxations in both RA and MA, which have previously been shown to involve Kv7 channels, 5, 8 and these were impaired in Kv7.4 morpholino-transfected vessels ( Figure 1G and 1H). 
Basal Associations Between Kv7.4 and Gβ in RA and MA
In the RA, inhibition of either Kv7 channels or Gβγ subunits produces contraction in the basal resting state (5, 8, and 12) . Therefore, we considered whether there were differences in the role Kv7 channels or Gβγ subunits in the basal resting state of RA and MA. In nonstimulated vessels, inhibition of Kv7 channels with 10 µmol/L linopirdine did not contract MA but produced a robust contraction of RA (Figure 2A) . Similarly, inhibition of the Gβγ interactions with 50 µmol/L gallein did not produce any effect in MA but contracted RA considerably ( Figure 2B ). PLA showed a lower level of Kv7.4-Gβ puncta in MA compared with RA in unstimulated cells while in RA, 50 µmol/L gallein treatment decreased Kv7.4-Gβ puncta to similar levels seen in MA, whereas gallein treatment had no effect in MA ( Figure 2C ).
Effect of Gβγ Inhibition on RA and MA Responses
We next considered the role of Gβγ subunits in isoproterenol-dependent relaxations in RA and MA. In RA, isoproterenol responses were impaired after Gβγ inhibition by either 50 µmol/L gallein or 10 µmol/L M119K ( Figure 3A and 3B). As shown in Figure 2C , gallein treatment of RA myocytes decreased the basal level of Kv7.4-Gβ puncta significantly (data shown again here for clarity), but no increase in puncta levels is seen with subsequent isoproterenol treatment ( Figure 3C ). However, in contrast to RA, isoproterenol relaxations in the MA were not sensitive to 50 µmol/L gallein ( Figure 4A ) although a slight attenuation was produced by 10 µmol/L M119K ( Figure 4B ). The number of Kv7.4-Gβ associations at rest in MA was less than in the RA (as shown in Figure 2C , data shown again here for clarity) but increased with isoproterenol treatment in a gallein-sensitive manner ( Figure 4C ). These data reveal a differential reliance on Gβγ for basal and isoproterenol-driven tone in MA compared with RA.
Examining Differing Gβγ Dependencies of Isoproterenol Effects in MA and RA
Subsequently, we investigated if the strong dependence on Gβγ for isoproterenol relaxations in RA compared with MA was because of the different intracellular mediators responsible for mediating the relaxation in the different beds. In RA, this is predominantly a PKA-dependent relaxation, whereas in MA, this relaxation is EPAC dependent. 9 Relaxations to the EPAC analogue 8-pCPT-2Me-cAMP-AM are inhibited by Kv7 channel blockers in the rat MA. 9 In the presence of gallein, the 8-pCPT-2Me-cAMP-AM (1 µmol/L) relaxation in MA still displayed linopirdine sensitivity ( Figure 5A ). Similarly, isoproterenol relaxations in the presence of gallein were still sensitive to both Kv7 and EPAC inhibition (10 µmol/L linopirdine and 100 nmol/L ESI-09, respectively; Figure 5B and 5C). Previous work showed that the EPAC-dependent isoproterenol relaxation of MA enhanced the association of Kv7.4 with Rap1a, 9 a small G protein downstream of EPAC in PLA experiments, and this was still apparent in the presence of gallein ( Figure 6A) . Conversely, the increase in the Kv7.4-AKAP association which occurs in RA with isoproterenol treatment 9 did not occur in the presence of gallein ( Figure 6B ).
Investigating the Effect of Gβγ Inhibition on CGRP Relaxations of the MA and CA
We next considered whether the role of the Gβγ-Kv7.4 relationship was something peculiar to isoproterenol or whether other vasorelaxants working via Kv7 channels display a similar dependence. CGRP is an effective relaxant of MAs 17 that works through a Gs-linked receptor. CGRP relaxations of the MA were markedly attenuated in vessels where Kv7.4 was knocked down by morpholino ( Figure 7A ) and by 10 µmol/L linopirdine ( Figure 7B ). Relaxations were also sensitive to 50 µmol/L gallein ( Figure 7C ) and 10 µmol/L M119K ( Figure 7D ). However, neither inhibition of PKA (1 µmol/L PKI and 1 µmol/L KT5720) nor EPAC (300 nmol/L ESI-09) had any effect on relaxations ( Figure I in the online-only Data Supplement). PLA showed an increase in the number of associations between Kv7.4 and the Gβ subunit in MA myocytes treated with 1 nmol/L CGRP ( Figure 7E ). CGRP-dependent relaxation of CA is impaired by Kv7 blockers (Chadha et al 3 and current study), and these relaxations were attenuated in CA where Kv7. 
Discussion
This study reveals that the role of the Kv7-Gβγ relationship in mediating relaxations is both receptor and artery specific. We show vessel-dependent differences in the Kv7.4-Gβγ relationship affects the basal vascular reactivity and that Gβγ signaling is a functional component of some vasorelaxant pathways. These findings demonstrate the sheer complexity involved in vascular control and response mechanisms and begin to uncover the subtle distinctions that can exist over different vascular beds in both signaling and ion channel mechanisms.
Role of Gβγ in Vascular Responsiveness
Gβγ are well documented as essential components of the heterotrimeric G protein complex, with increasingly recognized diverse roles in cellular signaling, such as regulation of adenylate cyclase, MAP (mitogen-activated protein) kinases, phospholipase C, and PI3 (phosphoinositide 3) kinases, 18, 19 but the role these subunits may play in vascular responsiveness remains ill defined. However, the identification that Gβγ are required for basal native vascular Kv7 channel activity in the RA, 12 which is strongly implicated in arterial regulation, provides a new mechanism for vascular control. Indeed, inhibition of Gβγ with gallein contracts the RA but not MA or CA, mirroring the effects of Kv7 channel inhibition in these vessels. It must be noted that Gβγ can also regulate the activity of other channels, such as CaV or K IR , [18] [19] [20] [21] and these interactions might play a role in vascular control mechanisms, an interesting avenue for future study. However, here we present compelling evidence that there are vascular bed differences in the activity of Kv7 channels and their associations with regulators which contribute to a complex myriad of vascular control mechanisms.
Previous work established a role for the Gβγ-Kv7 complex in basal vascular reactivity in the RA, showing an association between Kv7.4 and Gβ in the basal state which decreased with gallein treatment. 12 Functionally, this was associated with the generation of contractions of similar amplitude to those produced by Kv7 channel blockers. 12 Interestingly, in these studies examining different parts of the vasculature in more detail, that is, the MA and CA, no such basal association was seen between Kv7.4 and Gβ (Figures 2 and 8 ) and no such basal reactivity was seen in response to either Gβγ or Kv7 blockade to that seen in RA (Lee et al , and current study). This shows that there is distinct variation in the contribution of both Kv7 channels and Gβγ to basal regulatory control in different vascular beds.
Role of Gβγ in Receptor-Mediated Relaxations
Various receptor-dependent relaxations in RA, MA, and CA have previously implicated involvement of Kv7 channels as shown through pharmacological blockade and siRNA knockdown of Kv7.4 in the RA. 8, 9 To extend some of these previous findings, we used morpholino knockdown of Kv7.4, in all 3 vessels to study receptor-dependent relaxations. It must be noted for all of our findings that previous studies in various arteries have demonstrated isoproterenol or CGRP effects to involve K ATP , BK Ca , or other Kv channels. 9, [22] [23] [24] [25] [26] [27] [28] [29] That several potassium channels have been implicated in these relaxations is now a recurring theme in vascular physiology research. Although some of this may be because of species and vesseldependent differences, future studies must aim to integrate these many findings to establish how these individual mechanisms work in concert.
Knockdown of Kv7.4 channels resulted in marked attenuation of isoproterenol responses concomitant with decreased total Kv7.4 in all vessels. Further experiments showed that inhibition of Gβγ by gallein or the more potent M119K 16 prohibited isoproterenol relaxations in RA but had little effect on isoproterenol responses in the MA. Previous studies demonstrated that isoproterenol relaxations of the RA were PKA and AKAP dependent, whereas in the MA, they were EPAC dependent. 9 Therefore, we considered this as a possibility for the difference in the Gβγ dependence of these relaxations. Consequently, we tested the effect of Gβγ inhibition on EPAC-mediated relaxations by using the analogue 8-pCPT-2Me-cAMP-AM. These relaxations involved Kv7 channels but were not attenuated by Gβγ inhibition. This is consistent with the EPAC-dependent isoproterenol response in MA also not being gallein sensitive. However, Kv7 channel blockade still prevented EPAC and isoproterenol relaxation in MA in the presence of gallein, suggesting that Gβγ were not required for EPAC to increase Kv7 activity. Indeed, PLA studies show that the increase in Kv7.4-Rap1a association with isoproterenol treatment was not affected with Gβγ inhibition. Conversely, gallein treatment prevented the isoproterenol induced increase in AKAP-Kv7.4 association in the RA. This suggests that here the presence of Gβ is required for AKAP to associate with the channel complex but not for Rap proteins.
We considered that the Kv7-Gβγ relationship might be peculiar to isoproterenol-dependent effects and so investigated CGRP as another vasorelaxant mechanism that has been previously been shown to be Kv7 dependent in the CA. 3 CGRP relaxations in both MA and CA were attenuated by Kv7 blockade with linopirdine and by morpholino knockdown of Kv7.4. We also corroborated previous findings that established a role for Gβγ subunits in CGRP responses of the MA. 17 PLA experiments show that CGRP treatment increased Gβ-Kv7.4 puncta consistent with a greater association of Kv7.4 and Gβγ while both Gβγ inhibitors attenuated the relaxant response to CGRP considerably. Remarkably, in the cerebral vasculature, no such relationship was seen, with no association detected between Gβ-Kv7.4 in either control or CGRP-treated myocytes while Gβγ inhibitors had no effect on relaxations.
Raised cAMP in response to CGRP is a reasonably consistent finding in most vessels studied, and therefore relaxations will occur via PKA or EPAC. 27, 30, 31 While a role for PKA has been shown by some, 30 and our findings are in agreement with previous work that demonstrated PKA had no role in CGRP relaxations of the MA. 17 This would rule out a traditional cAMP-dependent relaxation pathway in the MA, and the high dependence on Gβγ activity would suggest that this is the main mechanism involved although the exact signals are currently unclear. The source of the Gβγ which is recruited to the Kv7.4 is unclear but may suggest a pool of free subunits close to the channel-a previously controversial view, but there is now a critical mass of evidence reporting the existence of such pools. [32] [33] [34] [35] Alternatively, the source of Gβγ may occur from translocation directly from receptor stimulation depending on the subcellular localization. Future studies will investigate the role of other Gβγ effectors (eg, enzyme cascades, other ion channels) in this process.
Of course, all experiments must be interpreted with the relevant caveats; it is possible that signaling intermediaries other than those described here may be involved in these processes, and the role of Kv7 channels and how they are regulated in the endothelium is unclear but may play a role here. In addition, the use of freshly isolated myocytes for PLA experiments, although in agreement with our functional data, may not represent the true picture in intact arteries as alterations may take place in the isolation process. There are many unknowns about how Gβγ function in vascular smooth muscle although they clearly have important roles as they have been implicated in proliferation and differentiation processes. 36, 37 So an added caveat is that Gβγ are involved in many different cellular processes and therefore their inhibition may produce manifold effects. There is the possibility that inhibition of these subunits prevents proper functioning of the receptor complexes. However, in the MA, isoproterenol relaxations are not affected, suggesting this receptor is still capable of functional signaling while vasoconstrictor stimuli in both vessels are not affected. We propose that 1 mechanism by which Gβγ are involved in vascular responsiveness is by regulating the activity and ability of Kv7.4 to respond to some intracellular signals. Future studies will aim to investigate the physiological significance of these findings in vivo on blood flow and pressure. These findings highlight the startling level of heterogeneity of receptor signaling across vascular beds and demonstrates the perils to extrapolate out findings from 1 vessel type to many. Here, we show 2 vasorelaxants in a total of 3 vessels which all involve Kv7 channels to some extent, but the signaling intermediaries are different in every situation. This study reveals a complex vascular bed-specific regulation of Kv7 channels by Gβγ subunits and the underlying requirement of this regulation for some, but not all, receptor-mediated effects on these channels. Overall, this study demonstrates the importance of the Kv7.4-Gβγ relationship in vascular control and gives an intriguing insight into novel vasorelaxant mechanisms by Gβγ.
